FDA Cracks Down on CBD Oil - Not Approved as a Supplement
Unless the FDA makes an exception, consumers will lose access to affordable CBD oil.
Over the last couple of years, ANH has been reporting on the many benefits of CBD oil, a non-psychoactive compound found in the hemp plant. Among other things, CBD oil is extremely helpful in managing pain.
You might think that, in the midst of a crippling epidemic of opioid addiction, a public health agency would be interested in preserving access to affordable, non-addictive pain remedies.
But the FDA could shut the door permanently on consumer access to affordable CBD oil, unless concerned citizens make their voices heard.
The agency has sent warning letters to several CBD companies for making illegal disease claims.
It is shocking that this issue has come to this. Deaths from fentanyl, an FDA-approved drug, and other synthetic opioids reached an appalling 30,000 in 2018.
When a safe, non-addictive, and effective alternative to deadly opioids is found, it is snatched away by Big Pharma with the help of the FDA, whose mission it is to protect public health. It is one of the most shameful examples of crony capitalism in recent memory.





























































